Compounds > bosentan anhydrous
Page last updated: 2024-08-26

bosentan anhydrous and Hereditary Hemorrhagic Telangiectasia

bosentan anhydrous has been researched along with Hereditary Hemorrhagic Telangiectasia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cachulo, Mdo C; Costa, GV; Leitão-Marques, AM; Lemos, CG; Providência, R; Silva, J1
Chang, SA; Jang, SY; Kang, IS; Ki, CS; Kim, DK1
Ewert, R; Felix, S; Opitz, C; Schlag, K; Wensel, R1
Adlbrecht, C; Bonderman, D; Lang, IM; Nowotny, R; Skoro-Sajer, N1

Other Studies

4 other study(ies) available for bosentan anhydrous and Hereditary Hemorrhagic Telangiectasia

ArticleYear
Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension?
    Arquivos brasileiros de cardiologia, 2010, Volume: 94, Issue:3

    Topics: Aged; Antihypertensive Agents; Bosentan; Fatal Outcome; Female; Humans; Hypertension, Pulmonary; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic

2010
Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.
    Heart and vessels, 2011, Volume: 26, Issue:2

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Bosentan; Echocardiography, Doppler; Endothelin Receptor Antagonists; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Recovery of Function; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Tomography, X-Ray Computed; Treatment Outcome

2011
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-10, Volume: 130, Issue:23

    Topics: Anticoagulants; Antihypertensive Agents; Bosentan; Calcium Channel Blockers; Diuretics; Endothelin Receptor Antagonists; Epistaxis; Epoprostenol; Female; Furosemide; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Nifedipine; Pedigree; Phenprocoumon; Pyridines; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Failure; Vasodilator Agents

2005
Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia.
    European journal of clinical investigation, 2006, Volume: 36 Suppl 3

    Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Middle Aged; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Outcome

2006